De-cancer / curatio / medicinae / prostatae

Cancer prostatae Medicamenta ad Approbata

Haec pagina lists cancer medicinae probatus fuerit per Quod Cibus et medicamentis Administration (FDA) ad prostate cancer. Album quod includit nomina generica et torris nomen. Quod pharmacum est scriptor nomina NCI ad cancer summaria medicamentis Information. Prostate cancer potest non esse medicinae usus est in eo sunt hic enumerantur.

Cancer prostatae Medicamenta ad Approbata

Abiraterone Acetate

Apalutamide

Bicalutamide

Cabazitaxel

Casodex (Bicalutamide)

Darolutamide

Degarelix

Docetaxel

Eligard (Leuprolide Acetate)

Enzalutamide

Erleada (Apalutamide)

Firmagon (Degarelix)

Flutamide

Goserelin Acetate

Jevtana (Cabazitaxel)

Leuprolide Acetate

Lupron (Leuprolide Acetate)

Lupron Depot (Leuprolide Acetate)

Mitoxantrone Hydrochloride

Nilandron (Nilutamide)

Nilutamide

Nubeqa (Darolutamide)

Provenge (Sipuleucel-T)

Radium CCXXIII Dichloride

Sipuleucel T-

Taxotere (Docetaxel)

Xofigo (CCXXIII Dichloride Radium)

Xtandi (Enzalutamide)

Zoladex (Goserelin Acetate)

Zytiga (Abiraterone Acetate)